The ICI Fund has awarded over $6.5M to 20 NCI-designated cancer centers.
{slider title="Baylor College of Medicine, Dan L. Duncan Comprehensive Cancer Center" class="icon awards"}
GEARBOx
- Donald (Will) Parsons, MD
{slider title="Dana-Farber Cancer Institute" class="icon awards"}
Maximizing the Robustness of Fragmentomics-based Cancer Biomarkers
- Sylvan C. Baca, MD, PhD
- Eliezer Van Allen, MD
Expanded Structural Variant Signatures and Their Role in Predicting Chemotherapy Sensitivity
- Rameen Beroukhim, MD, PhD
- Simona Sara Dalin, PhD
Designing T Cell Liquide Biopsies From Single-Cell Resolution Data
- Meromit Singer, PhD
- Adil Daud, MD
Deep Learning Models to Accelerate Translational Cancer Genomics
- Eliezer Van Allen, MD
- Haitham A. Elmarakeby, PhD
Novel Analytical Models Relating Genetic Ancestry to Cancer Risk in Large Panel Sequencing Datasets
- Jian Carrot-Zhang, PhD
MatchMiner: Accelerating Enrollment of Patients to Precision Cancer Medicine Clinical Trials
- Michael Hassett, MD, MPH
- Ethan Cerami, PhD
Integrated Genomic Analyses to Detect Oncogenic Rearrangements
- Remeen Beroukhim, MD, PhD
- Ofer Shapira, RhD
GEARBOx
- Katherine Janeway, MD
{slider title="Fred Hutchinson Cancer Research Center, University of Washington" class="icon awards"}
Accelerating the Development and Validation of Liquid Biopsy Assays for Cancer
- Colin C. Pritchard, MD, PhD
- Gavin Ha, PhD
High Dimensional Interference for Biomarker Identification: An Application to CAR-T Cell Immunotherapy
- Vicky Wu, PhD
- Jordan Gauthier, MD, MSc
{slider title="Harvard Medical School" class="icon awards"}
Drug Response Signatures in Rare Adrenocortical Carcinoma & Patient-Patient Similarity Networks
- Jaydira Del Rivero, MD (NCI)
- Augustin Luna, PhD
{slider title="Hugo W. Moser Research Institute at Kennedy Krieger" class="icon awards"}
Elucidate the Mechanism Underlying Resistance in Gliomas to Conventional Therapy
- Joseph Bressler, PhD
- John Laterra, MD, PhD
{slider title="Icahn School of Medicine at Mount Sinai" class="icon awards"}
A Network-Based Precision Medicine Platform for Personalized Treatment of Multiple Myeloma
- Samir Parekh, MD
- Joel Dudley, PhD
{slider title="Memorial Sloan Kettering Cancer Center" class="icon awards"}
Discovery and Validation of Splicing and Gene Expression Programs in Cancer
- Christina Leslie, PhD
- Eneda Toska, PhD
Multimodal Metabolic Analysis of Tumors and Therapeutic Responses
- Abraham A. Hakimi, MD
- Eduard Reznik, PhD
SIGNAL: A Population-Scale Resource of Germline Variants and Accompanying Somatic Alterations in Cancer
- Jianjiong Gao, PhD
- Michael Berger, PhD
- David Solit, MD
Unraveling the Tumor-Immune by Immunogenomic Analysis
- Dmitriy Zamarin, MD, PhD
Discovery and Validation of Tandem Mutations Driving Cancer
- Neil Vasan, MD, PhD
- Eduard Reznik, PhD
Identifying the Genomic Basis or Organ-Specific Metastasis
- Francisco Sanchez-Vega
- Karuna Ganesh, MD
Genome Nexus: A Web Resource for the Comprehensive Annotation of Cancer Variants
- Nikolaus Schultz, PhD
- Jianjiong Gao, PhD
GEARBOx
- Julie Glade Bender, MD
{slider title="National Cancer Institute" class="icon awards"}
Drug Response Signatures in Rare Adrenocortical Carcinoma & Patient-Patient Similarity Networks
- Jaydira Del Rivero, MD (NCI)
- Augustin Luna, PhD
{slider title="NYU Courant Institute of Mathematical Sciences" class="icon awards"}
Bridging Cancer Genomics Data Resources
- Bud Mishra, PhD
{slider title="Seattle Children's Hospital" class="icon awards"}
GEARBOx
- Douglas Hawkins, MD
{slider title="Stanford University School of Medicine" class="icon awards"}
Identifying Actionable Microbial Biomarkers for Cancer Therapy Using Big Data Approaches
- Hanlee Ji, MD
- Li Xia, PhD
Computational Epigenomics to Study Pancancer Etiology
- James Zou, PhD
- Olivier Gevaert, PhD
Identification of Factors Modulating Immune System Response to Tumors
- Maximilian Diehm, MD
- Andrew Gentles, PhD
Bridging Cancer Genomics Data Resources
- Daniele Ramazzotti, PhD
{slider title="The Research Institute at Fox Chase Cancer Center" class="icon awards"}
Evaluating Trial TRIAGE, a Point of Service Software Tool That Streamlines Selection of Patient Appropriate Clinical Trials
- Anthony J. Olszanski, MD, RPh
- Eric A. Ross, PhD, ScM
{slider title="Toyota Technological Institute at Chicago" class="icon awards"}
A Computational Platform for Analyzing Cancer Immunologic Data
- Aly Azeem Khan, PhD
{slider title="University of Cambridge" class="icon awards"}
Unraveling the Tumor-Immune Microenvironment by Immunogenomic Analysis
- Martin Miller, PhD
{slider title="University of Chicago" class="icon awards"}
A Computational Platform for Analyzing Cancer Immunologic Data
- Peter Savage, PhD
GEARBOx
- Samuel Volchenboum, MD, PhD
- Susan Cohn, MD
{slider title="University of Michigan School of Medicine" class="icon awards"}
Translational Tools and Resources to Advance MHC (HLA) Cancer Genetics
- Marcin Cieslik, PhD
- Ajjai Shivaram Alva, MBBS, MS
{slider title="University of Pittsburgh, Hillman Cancer Center" class="icon awards"}
Integrative Computational Framework for Linking Cell Surface Proteins to Downstream Transcriptional Programs in Cells
- Ashwin Somasundaram, MD
- Hatice Ulku Osmanbeyoglu, PhD
{slider title="University of Texas Health Center at San Antonio" class="icon awards"}
Deep Learning-Based Prognostic Model for Management of Men with Metastatic Castration-Resistant Prostate Cancer
- Yu-Chiao Chiu, PhD
- Yidong Chen, PhD
{slider title="University of Texas, MD Anderson" class="icon awards"}
TOM: Treatment Outcome Monitor - a cloud-based tool designed specifically for clinics with limited resources
- Laurence Court, PhD
- Joshua Niedzielski, PhD
Application of a Genomic/Transcriptomic Deconvolution Toolbox Addressing Tumor Heterogeneity of Consensus Molecular Subtypes in Metastatic and Primary Colorectal Cancer Samples
- Shaolong Cao, PhD
- Scott E. Kopetz, MD, PhD
Novel Analytical Models Relating Genetic Ancestry to Cancer Risk in Large Panel Sequencing Datasets
- Xiuning Le, MD, PhD
Genomics-Guided Discovery of Effective Combination Therapies in Cancer
- Scott Woodman, MD, PhD
- Anil Korkut, PhD
{slider title="St. Jude’s Children’s Research Hospital" class="icon awards"}
Accelerating the Development and Validation of Liquid Biopsy via Computational Error Suppression
- Xiaotu Ma, PhD
- Jeffery M. Klco, PhD
{/sliders}